Tilt table testing for assessing syncope

Journal of the American College of Cardiology

Volumn 28, Issue 1, 1996, Pages 263-275

  Benditt, David G ^a   Ferguson, David W ^a   Grubb, Blair P ^a   Kapoor, Wishwa N ^a   Kugler, John ^a   Lerman, Bruce B ^a   Maloney, James D ^a   Raviele, Antonio ^a   Ross, Bertrand ^a   Sutton, Richard ^a   Wolk, Michael J ^a   Wood, Douglas L ^a  

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HUMAN; MEDICAL RESEARCH; NOMENCLATURE; PATIENT POSITIONING; PRIORITY JOURNAL; REVIEW; SYNCOPE; TILTING;

EID: 0030199184     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00236-7     Document Type: Note

References (97)

1. 1. Kenny RA, Bayliss J, Ingram A, Sutton R. Head up tilt: a useful test for investigating unexplained syncope. Lancet 1986;1:1352-4.
2. 2. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle L. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. PACE 1988;11:1202-14.
3. 3. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-51.
4. 4. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in unexplained syncope. Lancet 1989;1:658-60.
5. 5. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992;3:180-3.
6. 6. Strasberg B, Rechavia E, Sagie A, et al. The head-up tilt table test in patients with syncope of unknown origin. Am Heart J 1989;118:923-7.
7. 7. Blanc JJ, Genet L, Mansourati J, et al. Interet du test d'inclinaison dans le diagnostic etiologique des pertes de connaissance. Presse Med 1990;19: 857-9.
8. 8. Raviele A, Gasparini G, DiPede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990;65:1322-7.
9. 9. Benditt DG, Remole S, Bailin S, Dunnigan A, Asso A, Milstein S. Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: rationale and proposed protocols. PACE 1991;14:1528-37.
10. 10. Grubb BP, Temesy-Armos P, Hahn H, Elliott L. Utility of upright tilt table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991;90:6-10.
11. 11. Thilenius OG, Quinones JA, Husayni TS, Novak J. Tilt test for diagnosis of unexplained syncope in pediatric patients. Pediatrics 1991;87:334-8.
12. 12. Lerman-Sagie T, Rechavia E, Strasberg B, Sagie A, Blieden L, Mimouni M. Head-up tilt for the evaluation of syncope of unknown origin in children. J Pediatr 1991;118:676-9.
13. 13. Grubb BP, Wolfe D, Samoil D, et al. Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management. J Am Geriatr Soc 1992;40:1123-8.
14. 14. Savage DD, Corwin L, McGee DL, Kannell WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985;16:626-9.
15. 15. Kapoor WN, Karpf M, Wieand S, et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204.
16. 16. Kapoor WN, Peterson J, Wieand HS, et al. Diagnostic and prognostic implication of recurrences in patients with syncope. Am J Med 1987;83: 700-8.
17. 17. Bass EB, Elson JJ, Fogoros RN, Peterson J, Arena VC, Kapoor WN. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol 1988;62:1186-91.
18. 18. Kapoor W. Evaluation and outcome of patients with syncope. Medicine 1990;69:160-175.
19. 19. Day SC, Cook EF, Fundenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;72:15-23.
20. 20. Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO. Patients with syncope admitted to medical intensive care units. JAMA 1982;248: 1185-9.
21. 21. Gendelman HE, Linzer M, Gabelman M, Smoller J. Syncope in a general hospital population. NY State J Med 1983;83:116-65.
22. 22. Martin GJ, Adams SL, Martin HG, et al. Prospective evaluation of syncope. Ann Emerg Med 1984;13:499-504.
23. 23. Benditt DG, Remole S, Milstein S, Bailin S. Syncope: causes, clinical evaluation, and current therapy. Annu Rev Med 1992;43:283-300.
24. 24. Wayne HH. Syncope: physiological considerations and an analysis of the clinical characteristics in 510 patient. Am J Med 1961;30:418-38.
25. 25. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalized population: prevalence, incidence, and associated risk. Q J Med 1961;55:45-55.
26. 26. Ross RT. Syncope. London: WB Saunders 1988.
27. 27. Dermksian G, Lamb LE. Syncope in a population of healthy young adults. JAMA 1958;168:1200-7.
28. 28. Benditt DG, Lurie KG, Adler SW, Sakaguchi SW. Rationale and methodology of head-up tilt table testing for evaluation of neurally mediated (cardioneurogenic) syncope. In: Zipes DP, Jalife J editors. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders 1995:1115-28.
29. 29. van Lieshout JJ, Wieling W, Karemaker JM, Eckberg DL. The vasovagal response. Clin Sci 1991;81:575-86.
30. 30. Chen M-Y, Goldenberg IF, Milstein S, et al. Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope. Am J Cardiol 1989;63:66-72.
31. 31. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res 1965;9:189-94.
32. 32. Sander-Jensen K, Secher NH, Astrup A, et al. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol 1986;251:R742-R748.
33. 33. Fitzpatrick A, Williams T, Ahmed R, et al. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Cardiac Pacing Electrophysiol 1992;2:121-8.
34. 34. deMey C, Enterling D. Assessment of the hemodynamic responses to single passive head-up tilt by non-invasive methods in normotensive subjects. Methods Find Exp Clin Pharmacol 1986;8:449-57.
35. 35. Fitzpatrick A, Theodorakis G, Varda P, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J 1991; 12:389-94.
36. 36. Fitzpatrick A, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125-30.
37. 37. Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995;76:267-72.
38. 38. Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995;92:54-8.
39. 39. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 1992;116:358-63.
40. 40. Hammill SC, Holmes DR, Wood DL, et al. Electrophysiologic testing in the upright position: improved evaluation of patients with rhythm disturbances using a tilt table. J Am Coll Cardiol 1984;4:65-71.
41. 41. Hellebrandt FA, Franseen EB. Physiologic study of vertical stance in man. Physiol Rev 1943;23:220-25.
42. 42. Brigden W, Howarth S, Sharpey-Shaefer EP. Postural changes in the peripheral blood-flow of normal subjects with observations on vasovagal fainting reactions as a result of tilting, the lordotic posture, pregnancy and spinal anesthesia. Clin Sci Lond 1950;9:79-90.
43. 43. Alicandri C, Fouad FM, Tarazi RC, Castle L, Morant V. Three cases of hypotension and syncope with ventricular pacing: possible role of atrial reflexes. Am J Cardiol 1978;42:137-42.
44. 44. Rowell LB. Adjustment to upright posture and blood loss. In: Human Circulation During Physical Stress. Oxford: Oxford University Press, 1986: 137-73.
45. 45. Benditt DG, Sakaguchi S, JJ, Remole S, Adler S, Lurie KG. Syncope. Diagnostic considerations and the role of tilt table testing. Cardiol Rev 1993;1:146-56.
46. 46. Waxman MB, Yao L, Cameron DA, Wald RW, Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor prone persons. Am J Cardiol 1989;63:58-65.
47. 47. McIntosh SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994;23:317-9.
48. 48. Imholz BP, Settells JJ, van der Meiracker AH, Wesseling KH, Wieling W. Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intraarterial pressure. Cardiovasc Res 1990;24:214-21.
49. 49. Petersen MEV, Williams TR, Sutton R. A comparison of non-invasive continuous finger blood pressure measurement (Finapres) with intra-arterial pressure during prolonged head-up tilt. Eur Heart J 1995;16:1647-54.
50. 50. Kapoor WN, Smith M, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994;97:78-88.
51. 51. Folino AF, Buja GF, Martini B, Miorelli M, Nava A, Prolonged cardiac arrest and complete AV block during upright tilt test in young patients with syncope of unknown originprognostic and therapeutic implications. Eur Heart J 1992;13:1416-21.
52. 52. Gatzoulis KA, Mamarelis IE, Apostolopoulos T, Dilavris P, Gialafos J, Toutouzas P. Polymorphic ventricular tachycardia during tilt table testing in patients with syncope and probable dysfunction of the sinus node. PACE 1995;18:1075-9.
53. 53. Kosinski DJ, Grubb BP, Elliott L, Dubois B. Treatment of malignant neurocardiogenic syncope with dual chamber cardiac pacing and fluoxetine hydrochloride. PACE 1995;18:1455-7.
54. 54. Fletcher GF, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A Statement for Health Professionals from the American Heart Association. Circulation 1990;82:2286-304.
55. 55. Sheldon R, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 1992;19:773-9.
56. 56. Grubb BP, Temesy-Armos P, Moore J, et al. The use of head-up tilt table testing in the evaluation and management of syncope in children and adolescents. PACE 1992;15:742-48.
57. 57. Sheldon R, Splawinski J, Killam S. Reproducibility of upright tilt-table tests in patients with syncope. Am J Cardiol 1992;69:1300-5.
58. 58. Grubb BP, Wolfe W, Temesy-Armos, P, Hahn H, Elliott L. Reproducibility of head upright tilt table test results in patients with syncope. PACE 1992;15:1477-81.
59. 59. Calkins H, Kadish A, Sousa J, Rosenheck S, Morandy F. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol 1991;67:207-9.
60. 60. Lurie KG, Dutton J, Mangat R, Newman D, Eisenberg S, Scheinman M. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt table testing. Am J Cardiol 1993;72:1286-90.
61. 61. Raviele A, Gasparini G, DiPede F, et al. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 1994;127:103-11.
62. 62. Ross BA, Hughes S, Anderson E, Gillette PC. Abnormal responses to orthostatic testing in children and adolescents with recurrent unexplained syncope. Am Heart J 1991;122:748-54.
63. 63. Pongiglione G, Fish F, Strasburger JF, Benson DW. Heart rate and blood pressure response to upright tilt in patients with unexplained syncope. J Am Coll Cardiol 1990;16:165-70.
64. 64. Sutton R, Petersen MEV. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol 1995;6:569-76.
65. 65. Sra JS, Ånderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head up tilt testing. Ann Intern Med 1991; 114:1013-9.
66. 66. Grubb BP, Temesy-Armos P, Samoil D, Wolfe D, Hahn H, Elliott L. Head upright tilt testing in the evaluation and management of young athletes with recurrent exercise-induced syncope. Med Sci Sports Exercise 1993;25:24-28.
67. 67. Sakaguchi S, Shultz J, Remote S, Adler S, Lurie K, Benditt D. Syncope associated with exercise a manifestation of neurally-mediated syncope. Am J Cardiol 1995;75:476-81.
68. 68. Calkins H, Seifert M, Morady F. Clinical presentation and long term follow-up of athletes with exercise-induced vasodepressor syncope. Am Heart J 1995;129:1159-64.
69. 69. Grubb BP, Gerard G, Rousch K, et al. Differentiation of convulsive syncope and epilepsy with head up tilt table testing. Ann Intern Med 1991;115:871-6.
70. 70. Jaeger FJ, Schneider L, Maloney JD, Cruse RP, Fouad-Tarazi FM. Vasovagal syncope: role of head-up tilt test in patients with positive ocular compression test. PACE 1990;13:1416-23.
71. 71. Benditt DG, Peterson M, Lurie K, Grubb BP, Sutton R. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 1995;122:204-9.
72. 72. Petersen MEV, Price D, Williams T, Jensen N, Riff K, Sutton R. Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome. PACE 1994;17:882-91
73. 73. Grubb BP, Rubin AM, Wolfe D, Temesy-Armos P, Hahn H, Elliott L. Head upright tilt table testing: a useful tool in the evaluation of recurrent vertigo of unknown origin associated with neurocardiogenic syncope or syncope. Otolaryngol Head Neck Surg 1992;107:570-5.
74. 74. Grubb BP, Samoil D, Temesy-Armos P, Hahn H. Elliott L. Episodic periods of neurally-mediated hypotension and bradycardia mimicking transient ischemic attacks in the elderly. Cardiol Elderly 1993;1:221-5.
75. 75. Rowe PC, Bou-Holaigah I, Kan J, Calkins H. Is neurally-mediated hypotension an unrecognized cause of chronic fatigue? Lancet 1995;345:623-4.
76. 76. Grubb BP, Hunt C, Samoil D, et al. Provocation of bradycardia and hypotension by head upright tilt table testing in survivors of the sudden infant death syndrome. PACE 1993;16:892.
77. 77. Grubb BP, Kosinski D, Pothoulakis AJ. New and emerging indications for head upright tilt table testing. Eur J Cardiac Pacing Electrophysiol 1995;5: 109-12.
78. 78. Chen XC, Chen MY, Remole S, et al. Reproducibility of head up tilt table testing for eliciting susceptibility to neurally-mediated syncope in patients without structural heart disease. Am J Cardiol 1992;69:755-60.
79. 79. Fish FA, Strasburger JF, Benson DW. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol 1992;70:605-9.
80. 80. deMey C, Enterling D. Variant responses impair the usefulness of passive upright tilt in drug research. Methods Find Exp Clin Pharmacol 1988;10:57-64.
81. 81. Blanc JJ, Mansourati J, Maheu B, Boughaleb D, Genet L. Reproducibility of a positive passive upright tilt test at a seven-day interval in patients with syncope. Am J Cardiol 1993;72:469-71.
82. 82. Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993;71:1289-92.
83. 83. Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-48.
84. 84. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995;25:65-9.
85. 85. Eagle KA, Black HR. The impact of diagnostic tests in evaluating patients with syncope. Yale J Bio Med 1983;56:1-8.
86. 86. Martin GJ, Adams SL, Martin HG, et al. Prospective evaluation of syncope. Ann Emerg Med 1984;13:499-504.
87. 87. Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiologic testing. Circulation 1995;92: 1819-24.
88. 88. Morillo C, Klein G, Jones D, Yee R. Time and frequency domain analyses of heart rate variability during orthostatic stress in patients with neurally mediated syncope. Am J Cardiol 1994;74:1258-62.
89. 89. Lippman IN, Stein KM, Lerman BB. Failure to decrease parasympathetic tone during upright tilt predicts a positive tilt-table test. Am J Cardiol 1995;75:591-5.
90. 90. Lipsitz L, Mietus J, Moody G, Goldberger A. Spectral characteristics of heart rate variability before and during postural tilt. Circulation 1990;6: 1803-10.
91. 91. Hayano J, Sakakibara Y, Yamada A, et al. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991;67:199-204.
92. 92. Theodorakis G, Kremastinos D, Avrambos G, Stefanakiis G, Karavolias G, Toutouzas P. Heart rate variability in patients with vasovagal syndrome. PACE 1992;15:2221-5.
93. 93. Pruvot E, Vesin J, Schlaepfer J, Fromer M, Kappenberger L. Autonomic imbalance assessed by heart rate variability analysis in vasovagal syncope. PACE 1994;17:2201-6.
94. 94. Vardas P, Kochiadakis G, Orfanakis A, Kalaitzakis M, Manios E. Intraindividual reproducibility of heart rate variability before and during postural tilt in patients with syncope of unknown origin. PACE 1994;17:2207-10.
95. 95. Madders M, Lipsitz L, Wei J, Pluchino F, Mark R. Impaired heart rate responses to cough and deep breathing in elderly patients with unexplained syncope. Am J Cardiol 1987;60:1368-72.
96. 96. Kapoor W, Karpf M, Maher Y, et al. Syncope of unknown origin: the need for a more cost-effective approach to its evaluation. JAMA 1982;247:2687-91.
97. 97. Calkins H, Byrne M, El-Atassi R, Kalbfleisch S, Langberg JJ, Morady F. The economic burden of unrecognized vasodepressor syncope. Am J Med 1993;95:473-9.